Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...
WEST VIRGINIA (WVNS) – As developers continue to expand the possibilities of artificial intelligence, there has been a growing demand for data centers nationally. Many lawmakers have said they hope to ...
Back in December, Senator Blackburn released a similar framework for AI safety measures, but this latest version adds stricter guidelines on the developers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results